Production (Stage)
China Pharma Holdings, Inc.
CPHI
$2.22
$0.010.45%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.74M | -4.74M | -4.40M | -3.56M | -3.08M |
| Total Depreciation and Amortization | 2.62M | 2.87M | 2.85M | 2.81M | 2.75M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 456.40K | 469.00K | 421.20K | 29.60K | 21.70K |
| Change in Net Operating Assets | 1.20M | 682.10K | 1.46M | 904.90K | -396.20K |
| Cash from Operations | -466.40K | -727.20K | 327.10K | 183.40K | -699.60K |
| Capital Expenditure | -38.40K | -23.40K | -39.60K | -67.50K | -11.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -60.50K | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -253.30K | -- | -- | -- | -- |
| Cash from Investing | -291.80K | -23.40K | -100.10K | -67.50K | -11.50K |
| Total Debt Issued | 520.10K | 1.58M | 1.55M | 1.05M | 1.56M |
| Total Debt Repaid | -492.80K | -1.53M | -1.98M | -1.49M | -1.49M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.40K | 51.00K | -432.20K | -438.20K | 73.10K |
| Foreign Exchange rate Adjustments | -66.30K | 48.30K | 42.60K | -5.80K | 31.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -796.90K | -651.10K | -162.50K | -328.00K | -606.00K |